The U.K. government wants to boost the local life sciences industry, and it hopes to entice American venture capital firms to ...

To support tenants using AI, life sciences buildings need increased slab loads, electricity and water, all expensive upgrades for owners.

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

Imagine the perfect drink — a cocktail, coffee, or kombucha, perhaps. Whatever the concoction, it came together iteratively — one taste test, one tweak at a time. In much the same way, mixing ...

Biotech Showcase™ returns to San Francisco during J.P. Morgan Healthcare Week, marking its 19 th year as a premier destination for global biopharma leaders to showcase their companies and technologies ...

Registration Questions? **Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once ...

In this episode, we’ll explore the nascent fields of space data and synthetic biology and identify key strategies for enterprises looking to benefit from recent advancements in science and technology.

For a stock that had been struggling for significance for much of the past year, this dramatic shift was not merely a rally — ...

The day that Athena Countouriotis, then the CEO of Turning Point Therapeutics, announced that the San Diego biotech was acquired by Bristol Myers Squibb for $4.1 billion, people were already asking ...

Every year, thousands of biotech breakthroughs stall. Not because the science failed, but because the story did. A survey of biotech investors found that 86% believe that fewer than half of management ...

180 Life Sciences Corp. has pivoted from a biotech to an Ethereum treasury, driving a massive stock price surge and a rebrand to ETHZilla. The company raised $425M via PIPE and $156M in convertible ...